Jump to:

Licence Changes and Product Updates

RSS

July 2010

Diovan for paediatric use

Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to...

New indication for Tyverb

Tyverb (lapatinib) has had its licence extended to include use in combination...

Deleted products 2010

The following products have been discontinued from the UK market this year....

June 2010

Pentasa Sachets licensed for paediatric use

Pentasa Sachets (mesalazine) are now licensed for use in children with mild to...

Crestor approved for paediatric and prophylactic use

Crestor (rosuvastatin) has been approved for two additional indications: heterozygous familial hypercholesterolaemia...

May 2010

Zocor for heterozygous familial hypercholesterolaemia

The licence for Zocor (simvastatin) has been extended to include use in...

New Ebixa packaging for easier administration

Ebixa (memantine) solution is now presented with a dispensing pump, allowing doses...

Efexor XL for the treatment of panic disorder

The licence for Efexor XL (venlafaxine) has been extended to include the...

Malignancy contraindication for Regranex

Following a review by the European Medicines Agency, product information for the...

Topiramate use broadened

The licensed indications for topiramate ( Topamax ) in the UK have...

GP Curriculum Centre

Educational resource for the learning and teaching of the
GP curriculum

Click here to read more

Deleted products

Cumulative list of products discontinued from the UK market
in 2010

Click here to read more

Treating psoriasis

Healthcare Republic resource centre for diagnosing and managing psoriasis

Click here to read more

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

 

Back to top